Xyrem sodium oxybate regulatory update

The FDA’s Peripheral and Central Nervous System Drugs Advisory Committee will review on March 15 ORPH’s NDA for its Xyrem oral solution based on gamma hydroxybutyrate (GHB) to treat cataplexy and exce...